The plasma BCL11A concentrations in lymph node metastasis LSCC patients (131.22μg/L) were higher than those in no lymph node metastasis LSCC patients (75.99μg/L, P = 0.011; Fig 1C). Here, BCL11A is linked to metastatic malignant neoplasm in the lymph nodes.